Extrakorporale Lungenunterstützung bei Patienten mit ARDS

Stefan Kluge; Barbara Sensen; Stephan Braune

doi:10.1055/s-0042-105942

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2017; 142(02): 88-95
DOI: 10.1055/s-0042-105942

Dossier

Extrakorporale Lungenunterstützung bei Patienten mit ARDS

Extracorporeal Lung Support in Patients with ARDS

Stefan Kluge

,

Barbara Sensen

,

Stephan Braune

Abstract

Das akute Lungenversagen (ARDS) ist gekennzeichnet durch eine schwere Gasaustauschstörung und bleibt eine Herausforderung für die moderne Intensivmedizin. Extrakorporale Lungenunterstützungsverfahren werden dank technologischer Fortschritte in den letzten Jahren zunehmend zur Therapie der schweren respiratorischen Insuffizienz auf der Intensivstation angewendet. Der folgende Beitrag erläutert die Unterschiede extrakorporaler Lungenunterstützungssysteme, Indikationen zu deren Anwendung und potenzielle Komplikationen dieser Therapieform.

Full Text

References

Literatur
1 Pichler P. Antretter H. Dunser M. et al. Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology. Med Klin Intensivmed Notfmed 2015; 110: 407-420
2 Fan E. Gattinoni L. Combes A. et al. Venovenous extracorporeal membrane oxygenation for acute respiratory failure: A clinical review from an international group of experts. Intensive Care Med 2016; 42: 712-724
3 Peek GJ. Mugford M. Tiruvoipati R. et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363
4 Karagiannidis C. Brodie D. Strassmann S. et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 2016; 42: 889-896
5 Barbaro RP. Odetola FO. Kidwell KM. et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 2015; 191: 894-901
6 Combes A. Brodie D. Bartlett R. et al. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014; 190: 488-496
7 Grimme I. Winter R. Kluge S. et al. Hypoxic cardiac arrest in pregnancy due to pulmonary haemorrhage. BMJ Case Rep 2012;
8 Serpa Neto A. Schmidt M. Azevedo LC. et al. Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis: Mechanical ventilation during ECMO. Intensive Care Med 2016; 42: 1672-1684
9 Braune S. Kienast S. Hadem J. et al. Safety of percutaneous dilatational tracheostomy in patients on extracorporeal lung support. Intensive Care Med 2013; 39: 1792-1809
10 Fuehner T. Kuehn C. Hadem J. et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185: 763-768
11 Langer T. Santini A. Bottino N. et al. "Awake" extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering. Crit Care 2016; 20: 150
12 Abrams DC. Prager K. Blinderman CD. et al. Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest 2014; 145: 876-882
13 Schaible T. Extracorporeal membrane oxygenation in children. Med Klin Intensivmed Notfmed 2015; 110: 438-444
14 Luyt CE. Brechot N. Demondion P. et al. Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med 2016; 42: 897-907
15 Kalbhenn J. Wittau N. Schmutz A. et al. Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion 2015; 30: 675-682
16 Paden ML. Conrad SA. Rycus PT. et al. Extracorporeal Life Support Organization Registry Report 2012. Asaio j 2013; 59: 202-210
17 Gray BW. Haft JW. Hirsch JC. et al. Extracorporeal life support: experience with 2000 patients. Asaio j 2015; 61: 2-7
18 Staudinger T. Extracorporeal lung support-news and future developments. Med Klin Intensivmed Notfmed 2016;
19 John S. Willam C. Lung and kidney failure. Pathogenesis, interactions, and therapy. Med Klin Intensivmed Notfmed 2015; 110: 452-458
20 Allardet-Servent J. Castanier M. Signouret T. et al. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study. Crit Care Med 2015; 43: 2570-2581
21 Nierhaus A. Frings D. Braune S. et al. Interventional lung assist enables lung protective mechanical ventilation in acute respiratory distress syndrome. Minerva Anestesiol 2011; 77: 797-801
22 Terragni PP. Del Sorbo L. Mascia L. et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009; 111: 826-835
23 Bein T. Weber-Carstens S. Goldmann A. et al. Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 2013; 39: 847-856
24 Fitzgerald M. Millar J. Blackwood B. et al. Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care 2014; 18: 222
25 Burki NK. Mani RK. Herth FJ. et al. A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 2013; 143: 678-686
26 Abrams DC. Brenner K. Burkart KM. et al. Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013; 10: 307-314
27 Braune SA. Kluge S. Extracorporeal lung support in patients with chronic obstructive pulmonary disease. Minerva Anestesiol 2013; 79: 934-943
28 Westhoff M. Schonhofer B. Neumann P. et al. Noninvasive Mechanical Ventilation in Acute Respiratory Failure. Pneumologie 2015; 69: 719-756
29 Kreppein U. Litterst P. Westhoff M. Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management. Med Klin Intensivmed Notfmed 2016; 111: 196-201
30 Kluge S. Braune SA. Engel M. et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 2012; 38: 1632-1639
31 Del Sorbo L. Pisani L. Filippini C. et al. Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 2015; 43: 120-127
32 Braune S. Sieweke A. Brettner F. et al. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med 2016; 42: 1437-1444
33 Sklar MC. Beloncle F. Katsios CM. et al. Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med 2015; 41: 1752-1762